The deal size was increased to $140M in common stock from $100M in common stock. JPMorgan, Citi and Guggenheim acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYPT:
- EyePoint announces $100M offering of common stock
- EyePoint announces interim 16-week data for ongoing Phase 2 VERONA trial
- EYPT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- EyePoint announces first patient dosed in global Phase 3 LUGANO trial
- ANI Pharmaceuticals price target raised to $62 from $60 at Truist